This figure is only in Nigeria!!!! Imagine what happens if NICOSAN is approved in the EU and sold all over the world??? In the US the company is quoting around $24,000 per year per patient!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.